Cite

HARVARD Citation

    Lee, J. et al. (2017). Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity. European journal of cancer. pp. 125-133. [Online]. 
  
Back to record